These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 28403912)
21. Small molecules and small molecule drugs in regenerative medicine. Lu B; Atala A Drug Discov Today; 2014 Jun; 19(6):801-8. PubMed ID: 24252867 [TBL] [Abstract][Full Text] [Related]
22. [Translational research of cell sheet-based myocardial regeneration therapy]. Miyagawa S Nihon Yakurigaku Zasshi; 2016 May; 147(5):269-71. PubMed ID: 27181720 [No Abstract] [Full Text] [Related]
23. Balancing Safety and Efficacy With Early Availability in the Regulation of Regenerative Medicine Product. Fujiwara Y; Maruyama Y; Honda F Clin Pharmacol Ther; 2021 May; 109(5):1182-1185. PubMed ID: 32979224 [No Abstract] [Full Text] [Related]
29. The birth of 'regenerative pharmacology': a clinical perspective. Choudhury TR; Mathur A Br J Pharmacol; 2013 May; 169(2):239-46. PubMed ID: 23425309 [No Abstract] [Full Text] [Related]
30. CellCAN: a unique enabler of regenerative medicine and cell therapy in Canada. Roy DC; Alarco AM; Isasi R Stem Cells Dev; 2014 Dec; 23 Suppl 1():24-8. PubMed ID: 25457957 [TBL] [Abstract][Full Text] [Related]
31. Prospects for regenerative medicine approaches in women's health. Schenke-Layland K; Brucker SY J Anat; 2015 Dec; 227(6):781-5. PubMed ID: 26173979 [TBL] [Abstract][Full Text] [Related]
32. Regenerative medicine for Parkinson's disease. Yasuhara T; Kameda M; Agari T; Date I Neurol Med Chir (Tokyo); 2015; 55(2):113-23. PubMed ID: 25746305 [TBL] [Abstract][Full Text] [Related]
33. [Regenerative cell therapy]. Le Douarin N C R Biol; 2007; 330(6-7):457-64. PubMed ID: 17631438 [No Abstract] [Full Text] [Related]
35. Induced pluripotent stem cells and their implication for regenerative medicine. Csobonyeiova M; Polak S; Koller J; Danisovic L Cell Tissue Bank; 2015 Jun; 16(2):171-80. PubMed ID: 25037593 [TBL] [Abstract][Full Text] [Related]
36. [Development of Cellular and Tissue-based Products for Retinal Regenerative Medicine]. Osakada F Yakugaku Zasshi; 2017; 137(1):23-29. PubMed ID: 28049891 [TBL] [Abstract][Full Text] [Related]
37. Then and now: hypes and hopes of regenerative medicine. Slingerland AS; Smits AI; Bouten CV Trends Biotechnol; 2013 Mar; 31(3):121-3. PubMed ID: 23280408 [No Abstract] [Full Text] [Related]
38. Novel paths towards neural cellular products for neurological disorders. Daadi MM Regen Med; 2011 Nov; 6(6 Suppl):25-30. PubMed ID: 21999259 [TBL] [Abstract][Full Text] [Related]
39. First Approval of Regenerative Medical Products under the PMD Act in Japan. Konishi A; Sakushima K; Isobe S; Sato D Cell Stem Cell; 2016 Apr; 18(4):434-5. PubMed ID: 27058934 [No Abstract] [Full Text] [Related]
40. Cell-based therapies for the preterm infant. Zhu D; Wallace EM; Lim R Cytotherapy; 2014 Dec; 16(12):1614-28. PubMed ID: 25154811 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]